Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein.

Por Schlichtholz, B., Trédaniel, J., Lubin, R., Zalcman, G., Hirsch, A., Soussi, T.
Publicado em 1994

Detection and monitoring of serum p53 antibodies in patients with colorectal cancer.

Por Hammel, P, Boissier, B, Chaumette, M T, Piedbois, P, Rotman, N, Kouyoumdjian, J C, Lubin, R, Delchier, J C, Soussi, T
Publicado em 1997

Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases.

Por Laurent-Puig, P, Lubin, R, Semhoun-Ducloux, S, Pelletier, G, Fourre, C, Ducreux, M, Briantais, M J, Buffet, C, Soussi, T
Publicado em 1995

Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies

Por Moch, C, Moysan, A, Lubin, R, Salmonière, P de La, Soufir, N, Galisson, F, Vilmer, C, Venutolo, E, Pelletier, F Le, Janin, A, Basset-Séguin, N
Publicado em 2001